IART
Integra LifeSciences Holdings
16.10$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.9% | +12.4% | +19.8% | +23.9% | +3.1% | -9.6% | +12.4% | +1.0% | -1.0% | +4.5% | +1.5% | |
| – | -7.4% | +6.9% | +24.8% | +31.2% | -1.2% | -7.8% | +14.8% | -1.7% | +11.8% | +10.9% | +8.4% | |
| – | -3.4% | +15.6% | +17.1% | +19.7% | +5.8% | -10.7% | +11.0% | +2.7% | -8.8% | -0.3% | -4.2% | |
| – | -1.4% | +14.3% | +9.1% | +23.0% | +2.0% | -2.8% | +20.3% | +8.8% | +3.0% | +10.7% | -14.2% | |
| – | -6.8% | +9.6% | +37.0% | +10.7% | -0.5% | -13.5% | +7.2% | -3.3% | +6.5% | +9.2% | -2.4% | |
| – | -6.5% | +10.7% | +34.2% | +11.6% | +8.8% | -18.6% | +6.8% | -2.1% | +5.7% | +10.4% | -9.0% | |
| – | +21.4% | +44.9% | -61.2% | +147.7% | -15.5% | +61.4% | +30.3% | +21.1% | -53.3% | -74.5% | +140.5% | |
| – | +7.1% | +9.7% | +35.7% | +84.7% | -16.6% | +32.7% | -29.6% | -1.6% | +3.6% | +37.5% | +22.1% | |
| – | +41.2% | +49.0% | -87.4% | +404.2% | +4.7% | +55.6% | +129.6% | -0.4% | -62.1% | -122.5% | – | |
| – | +499.7% | -70.6% | -436.8% | – | – | -507.7% | – | -26.9% | -60.0% | -184.7% | – | |
| – | -110.3% | – | -13.2% | -6.1% | -17.4% | +166.7% | +26.3% | +6.8% | -62.5% | -110.3% | – | |
| – | +13.6% | +18.5% | -41.6% | +78.2% | -7.3% | +19.9% | +36.7% | +5.0% | -33.4% | -24.5% | -268.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.